AF
VIRS

Allworth Financial’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Allworth Financial’s Portfolio VIRS Stock Details VIRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-133
Closed -$4.82K – 3810
2024
Q1 		$4.82K Buy
+133
New +$4.57K ﹤0.01% 2424

Other funds holding VIRS

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allworth Financial's VIRS Position: Q2 2024 in Review

Allworth Financial sold out of Pacer BioThreat Strategy ETF (VIRS) in Q2 2024, closing a stake of 133 shares — an estimated $4.82K sold.

Allworth Financial first reported a position in VIRS in Q1 2024 and held it in 1 quarter. The position peaked at $4.82K in Q1 2024. 6 funds tracked by Wall St. Rank hold VIRS as of Q2 2024.

  • Allworth Financial reported no remaining Pacer BioThreat Strategy ETF position as of Q2 2024 after selling out during the quarter.
  • Allworth Financial sold 133 Pacer BioThreat Strategy ETF shares in Q2 2024, an estimated $4.82K.
  • Allworth Financial first reported a position in Pacer BioThreat Strategy ETF in Q1 2024 and held it in 1 quarter.
  • Allworth Financial's Pacer BioThreat Strategy ETF position peaked at $4.82K in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q2 2024.

Based on Allworth Financial's 13F filing for Q2 2024, filed 24 Jul 2024.